1. Efficacy and safety of glecaprevir/pibrentasvir as retreatment therapy for patients with genotype 2 chronic hepatitis C who failed prior sofosbuvir plus ribavirin regimen. Issue 10 (10th July 2019) Authors: Kusakabe, Atsunori; Kurosaki, Masayuki; Itakura, Jun; Joko, Kouji; Akahane, Takehiro; Tsuji, Keiji; Kobashi, Haruhiko; Sohda, Tetsuro; Kimura, Hiroyuki; Narita, Ryouichi; Furuta, Koichirou; Izumi, Namiki Journal: Hepatology research Issue: Volume 49:Issue 10(2019) Page Start: 1121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗